Taxotere and Ulcerative colitis - a phase IV clinical study of FDA data

Summary:

Ulcerative colitis is reported as a side effect among people who take Taxotere (docetaxel), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Herceptin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Ulcerative colitis when taking Taxotere. It is created by eHealthMe based on reports of 62,318 people who have side effects when taking Taxotere from the FDA, and is updated regularly.

What is Taxotere?

Taxotere has active ingredients of docetaxel. It is often used in breast cancer. eHealthMe is studying from 62,513 Taxotere users. Check the latest studies of Taxotere.

What is Ulcerative colitis?

Ulcerative colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine) is found to be associated with 1,195 drugs and 2,055 conditions by eHealthMe. Check the latest studies of Ulcerative colitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

62,318 people reported to have side effects when taking Taxotere.
Among them, 42 people (0.07%) have Ulcerative colitis.

Could Taxotere cause Ulcerative colitis?

Among these 42 people:

How long have people been on Taxotere when they have Ulcerative colitis? *

What is the gender of people who have Ulcerative colitis when taking Taxotere? *

female: 86.84 %
male: 13.16 %

What is the age of people who have Ulcerative colitis when taking Taxotere? *

What are other drugs people take besides Taxotere? *

What are other side effects people have besides Ulcerative colitis? *

Diarrhea: 22 people, 52.38%
Acute Kidney Failure: 15 people, 35.71%
Anaemia (lack of blood): 14 people, 33.33%
Weight Increased: 13 people, 30.95%
Joint Pain: 12 people, 28.57%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 12 people, 28.57%
Fever: 12 people, 28.57%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 12 people, 28.57%
Neuropathy Peripheral (surface nerve damage): 12 people, 28.57%
Constipation: 12 people, 28.57%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 6 people, 14.29%
Acne (skin problems that cause pimples): 3 people, 7.14%
Pain: 2 people, 4.76%
Prostate Cancer: 1 person, 2.38%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 2.38%
Idiopathic Thrombocytopenic Purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 1 person, 2.38%
Gastritis (inflammation of stomach): 1 person, 2.38%
Cough: 1 person, 2.38%
Constipation: 1 person, 2.38%
Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue): 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Taxotere and have Ulcerative colitis?

- Check whether Ulcerative colitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Taxotere:

Taxotere (62,513 reports)

Browse all side effects of Taxotere:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ulcerative colitis:

Ulcerative colitis (1,195 drugs)

Browse all the conditions that are associated with Ulcerative colitis:

Ulcerative colitis (2,055 conditions)

Related publications that referenced our studies

Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .
Byun JS, Kang SH, Lee MJ, Kim SY, Choi HG, Lee HR, "A Case of Scleroderma-like Cutaneous Lesions Induced by Docetaxel in a Patient with Breast Cancer", Journal of Rheumatic Diseases, 2013 Oct .

How the study uses the data?

The study uses data from the FDA. It is based on docetaxel (the active ingredients of Taxotere) and Taxotere (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.